Phase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS LymphomaDokumenPhase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS LymphomaDitambahkan oleh Shiro0 penilaian0% menganggap dokumen ini bermanfaatSimpan Phase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS Lymphoma untuk nanti